Barinthus Biotherapeutics plc
$0.75
+0.02 (+2.07%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +34.0%
- 3 Months
- +9.6%
- YTD
- +6.6%
- 1 Year
- -34.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 78.5%
- Largest decline max drawdown, since Aug 2025
- -65.9%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.15
Own BRNS?
See how BRNS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.